Mycobacterium wolinskyi: A Rare Strain Isolated in a Persistent Prosthetic Knee Joint Infection: A Case Report.


Journal

JBJS case connector
ISSN: 2160-3251
Titre abrégé: JBJS Case Connect
Pays: United States
ID NLM: 101596828

Informations de publication

Date de publication:
Historique:
pubmed: 3 8 2019
medline: 17 6 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

A patient who underwent first-stage revision procedure elsewhere for prosthetic joint infection (PJI) of the knee with Kocuria rosea presented to us 9 months after the index surgery, with persistent infection. First-stage revision surgery was repeated and Mycobacterium wolinskyi, a rare rapidly growing nontuberculous mycobacterium (RGM), was isolated from samples obtained by sonication of the cement spacer. After a prolonged antibiotic course, definitive implantation surgery was done. One-year postimplantation, patient remains infection free. This is only the second known case of knee PJI caused by M. wolinskyi. This case highlights the possibility of RGM getting masked by other organisms.

Identifiants

pubmed: 31373914
doi: 10.2106/JBJS.CC.18.00315
pii: 01709767-201909000-00017
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0315

Références

Peel TN, Cheng AC, Buising KL, Choong PF. Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective? Antimicrob Agents Chemother. 2012;56(5):2386-91.
Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD, Steckelberg JM, Gullerud R, Osmon DR. Culture-negative prosthetic joint infection. Clin Infect Dis. 2007;45(9):1113-9.
Malekzadeh D, Osmon DR, Lahr BD, Hanssen AD, Berbari EF. Prior use of antimicrobial therapy is a risk factor for culturenegative prosthetic joint infection. Clin Orthop Relat Res. 2010;468:2039-45.
Yoon HK, Cho SH, Lee DY, Kang BH, Lee SH, Moon DG, Kim DH, Nam DC, Hwang SC. A review of the literature on culture-negative periprosthetic joint infection:epidemiology, diagnosis and treatment. Knee Surg Relat Res. 2017;29(3):155-64.
Yang SC, Hsueh PR, Lai HC, Teng LJ, Huang LM, Chen JM, Wang SK, Shie DC, Ho SW, Luh KT. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother. 2003;47(6):1958-62.
Goswami K, Parvizi J, Maxwell Courtney P. Current recommendations for the diagnosis of acute and chronic PJI for hip and knee-cell counts, alpha-defensin, leukocyte esterase, next-generation sequencing. Curr Rev Musculoskelet Med. 2018;11(3):428-8.
CLSI. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard—Second Edition. CLSI Document M24-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.
Marculescu CE, Berbari EF, Cockerill FR III, Osmon DR. Fungi, mycobacteria,zoonotic and other organisms in prosthetic joint infection. Clin Orthop Relat Res. 2006;451:64-72.
Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis. 2007;45:687-94.
Amit P, Rastogi S, Marya S. Prosthetic knee joint infection due to Mycobacterium abscessus. Indian J Orthop. 2017;51(3):337-42.
Jitmuang A, Yuenyongviwat V, Charoencholvanich K, Chayakulkeeree M. Rapidly-growing mycobacterial infection: a recognized cause of early-onset prosthetic joint infection. BMC Infect Dis. 2017;17(1):802.
Brown BA, Springer B, Steingrube VA, Wilson RW, Pfyffer GE, Garcia MJ, Menendez MC, Rodriguez-Salgado B, Jost KC Jr, Chiu SH, Onyi GO, Bottger EC, Wallace RJ Jr. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol. 1999;49(4):1493-511.
Kannaiyan K, Ragunathan L, Sakthivel S, Sasidar AR, Muralidaran, Venkatachalam GK. Surgical site infections due to rapidly growing mycobacteria in puducherry, India. J Clin Diagn Res. 2015;9(3):DC05-8.
Selvaraju SB, Khan IU, Yadav JS. Biocidal activity of formaldehyde and nonformaldehyde biocides toward Mycobacterium immunogenum and Pseudomonas fluorescens in pure and mixed suspensions in synthetic metal working fluid and saline. Appl Environ Microbiol. 2005;71(1):542-6.
Phillips MS, von Reyn CF. Nosocomial infections due to nontuberculous mycobacteria. Clin Infect Dis. 2001;33(8):1363-74.
Pulcini C, Vandenbussche E, Podglajen I, Sougakoff W, Truffot-Pernot C, Buu-Hoï A, Varon E, Mainardi JL. Hip prosthesis infection due to Mycobacterium wolinskyi. J Clin Microbiol. 2006;44(9):3463-4.
Lee YS, Nam SW, Park YS, Lee BK. Mycobacterium wolinskyi infection after total knee arthroplasty in a healthy woman. J Orthop Sci. 2015;20(1):229-31.
Ariza-Heredia EJ, Dababneh AS, Wilhelm MP, Wengenack NL, Razonable RR, Wilson JW. Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis. 2011;71(4):421-7.
Stackebrandt E, Koch C, Gvozdiak O, Schumann P. Taxonomic dissection of the genus Micrococcus: Kocuria gen. nov., Nesterenkonia gen. nov., Kytococcus gen. nov., Dermacoccus gen. nov., and Micrococcus Cohn 1872 gen. emend. Int J Syst Bacteriol. 1995;45(4):682-92.
Garcia DC, Nascimento R, Soto V, Mendoza CE. A rare native mitral valve endocarditis successfully treated after surgical correction. BMJ Case Rep. 2014:2014.

Auteurs

Nishit Bhatnagar (N)

Department of Orthopaedics, Indraprastha Apollo Hospital, New Delhi, India.

Aruna Poojary (A)

Department of Pathology and Microbiology, Breach Candy Hospital, Mumbai, India.

Adit Maniar (A)

Lilavati Hospital & Research Centre and Breach Candy Hospital, Mumbai, India.

Armaity Contractor (A)

Breach Candy Hospital, Mumbai, India.

Seema Rohra (S)

Department of Pathology and Microbiology, Breach Candy Hospital, Mumbai, India.

Gaurav Kumar (G)

Jhansi Orthopaedic Hospital, Jhansi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH